General Info

GTx is a biopharmaceutical company dedicated to the discovery, development and commercialization of therapeutics primarily related to the treatment of serious men s health conditions and oncology. Its drug discovery and development programs are focused on small molecules that selectively modulate the effects of estrogens and androgens. In addition, the company has a marketed product and nearly five clinical programs. GTx also has an extensive preclinical pipeline generated from its own discovery program, which includes the specific product candidates prostarine and andromustine. GTx has a location in Memphis, Tenn.